Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 147

1.

Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals.

Bazerbachi F, Haffar S, Wang Z, González JC, Arias-Loste MT, Crespo J, Darwish-Murad S, Ikram MA, Olynyk JK, Gan E, Petta S, Berzuini A, Prati D, de Lédinghen V, Wai-Sun Wong V, Del Poggio P, Chávez-Tapia NC, Chen YP, Cheng PN, Yuen MF, Das K, Chowdhury A, Caballeria L, Fabrellas N, Ginès P, Kumar M, Sarin SK, Conti F, Andreone P, Sirli R, Cortez-Pinto H, Carvalhana S, Sugihara T, Kim SU, Parikh P, Chayama K, Corpechot C, Kim KM, Papatheodoridis G, Alsebaey A, Kamath PS, Murad MH, Watt KD.

Clin Gastroenterol Hepatol. 2018 Sep 7. pii: S1542-3565(18)30948-0. doi: 10.1016/j.cgh.2018.08.069. [Epub ahead of print] Review.

PMID:
30196155
2.

Renovation of Annals of Hepatology's Scientific Scope: Towards Preventing Rather Than Treating End-Stage Liver Disease.

Panduro A, Tiribelli C, Chávez-Tapia NC, Arrese M, Uribe M.

Ann Hepatol. 2018 July - August ,;17(4):539-540. doi: 10.5604/01.3001.0012.0913. No abstract available.

3.

The Mexican consensus on the treatment of hepatitis C.

Aiza-Haddad I, Ballesteros-Amozurrutia A, Borjas-Almaguer OD, Castillo-Barradas M, Castro-Narro G, Chávez-Tapia N, Chirino-Sprung RA, Cisneros-Garza L, Dehesa-Violante M, Flores-Calderón J, Flores-Gaxiola A, García-Juárez I, González-Huezo MS, González-Moreno EI, Higuera-de la Tijera F, Kershenobich-Stalnikowitz D, López-Méndez E, Malé-Velázquez R, Marín-López E, Mata-Marín JA, Méndez-Sánchez N, Monreal-Robles R, Moreno-Alcántar R, Muñoz-Espinosa L, Navarro-Alvarez S, Pavia-Ruz N, Pérez-Ríos AM, Poo-Ramírez JL, Rizo-Robles MT, Sánchez-Ávila JF, Sandoval-Salas R, Torre A, Torres-Ibarra R, Trejo-Estrada R, Velarde-Ruiz Velasco JA, Wolpert-Barraza E, Bosques-Padilla F.

Rev Gastroenterol Mex. 2018 Jul - Sep;83(3):275-324. doi: 10.1016/j.rgmx.2017.11.001. Epub 2018 May 24. English, Spanish.

4.

A New Stage in Annals of Hepatology.

Panduro A, Tiribelli C, Chávez-Tapia NC, Uribe M.

Ann Hepatol. 2018 May-June;17(3):339-340. doi: 10.5604/01.3001.0011.7377. Epub 2018 Apr 9. No abstract available.

5.

The importance of intra-hospital pharmacovigilance in the detection of medication errors

Villegas F, Figueroa-Montero D, Barbero-Becerra V, Juárez-Hernández E, Uribe M, Chávez-Tapia N, González-Chon O.

Gac Med Mex. 2018;154(2):172-179. doi: 10.24875/GMM.18002549. Spanish.

6.

Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis.

Sánchez-Jiménez BA, Brizuela-Alcántara D, Ramos-Ostos MH, Alva-López LF, Uribe-Esquivel M, Chávez-Tapia NC.

Alcohol. 2018 Jun;69:63-67. doi: 10.1016/j.alcohol.2017.11.004. Epub 2017 Nov 15.

PMID:
29660603
7.

The role of the gut microbiota in the pathology and prevention of liver disease.

Altamirano-Barrera A, Uribe M, Chávez-Tapia NC, Nuño-Lámbarri N.

J Nutr Biochem. 2018 Oct;60:1-8. doi: 10.1016/j.jnutbio.2018.03.006. Epub 2018 Mar 16. Review.

PMID:
29653359
8.

The management of incidental fatty liver found on imaging. What do we need to do?

Méndez-Sánchez N, Chavez-Tapia NC, Almeda-Valdes P, Uribe M.

Am J Gastroenterol. 2018 Sep;113(9):1274-1276. doi: 10.1038/s41395-018-0047-2. Epub 2018 Mar 16. No abstract available.

PMID:
29549356
9.

The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.

González-Regueiro JA, Moreno-Castañeda L, Uribe M, Chávez-Tapia NC.

Ann Hepatol. 2017 Nov;16(Suppl. 1: s3-105.):16-21. doi: 10.5604/01.3001.0010.5672. Review.

10.

Liver toxicity mechanisms of herbs commonly used in Latin America.

López-Gil S, Nuño-Lámbarri N, Chávez-Tapia N, Uribe M, Barbero-Becerra VJ.

Drug Metab Rev. 2017 Aug;49(3):338-356. doi: 10.1080/03602532.2017.1335750. Epub 2017 Jul 4. Review.

PMID:
28571502
11.

Biomarkers in hepatocellular carcinoma: an overview.

Juárez-Hernández E, Motola-Kuba D, Chávez-Tapia NC, Uribe M, Barbero Becerra V.

Expert Rev Gastroenterol Hepatol. 2017 Jun;11(6):549-558. doi: 10.1080/17474124.2017.1311785. Epub 2017 Apr 11. Review.

PMID:
28347162
12.

Less liver fibrosis in metabolically healthy compared with metabolically unhealthy obese patients with non-alcoholic fatty liver disease.

Gutiérrez-Grobe Y, Juárez-Hernández E, Sánchez-Jiménez BA, Uribe-Ramos MH, Ramos-Ostos MH, Uribe M, Chávez-Tapia NC.

Diabetes Metab. 2017 Sep;43(4):332-337. doi: 10.1016/j.diabet.2017.02.007. Epub 2017 Mar 16.

PMID:
28318912
13.

Diagnostic accuracy of nodular gastritis for H. pylori infection.

Romero-Flores JL, Fernandez-Rivero JA, Marroquín-Fabian E, Téllez-Ávila FI, Sánchez-Jiménez BA, Juárez-Hernández E, Uribe M, Chávez-Tapia NC.

Ther Clin Risk Manag. 2016 Dec 16;13:9-14. doi: 10.2147/TCRM.S121735. eCollection 2017.

14.

Validation of prognostic scores for clinical outcomes in cirrhotic patients with acute variceal bleeding.

Motola-Kuba M, Escobedo-Arzate A, Tellez-Avila F, Altamirano J, Aguilar-Olivos N, González-Angulo A, Zamarripa-Dorsey F, Uribe M, Chávez-Tapia NC.

Ann Hepatol. 2016 Nov-Dec 2016;15(6):895-901.

15.

Elevated cholesterol levels have a poor prognosis in a cholestasis scenario.

Nuño-Lámbarri N, Barbero-Becerra VJ, Uribe M, Chávez-Tapia NC.

J Biochem Mol Toxicol. 2017 Jan;31(1):1-6. doi: 10.1002/jbt.21831. Epub 2016 Aug 12. Review.

PMID:
27517733
16.

Role of bioactive fatty acids in nonalcoholic fatty liver disease.

Juárez-Hernández E, Chávez-Tapia NC, Uribe M, Barbero-Becerra VJ.

Nutr J. 2016 Aug 2;15(1):72. doi: 10.1186/s12937-016-0191-8. Review.

17.

Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach.

Nuño-Lámbarri N, Barbero-Becerra VJ, Uribe M, Chávez-Tapia NC.

Int J Mol Sci. 2016 Mar 15;17(3):281. doi: 10.3390/ijms17030281. Review.

18.

Prevalence of hepatitis C virus infection among patients undergoing haemodialysis in Latin America.

Gómez-Gutiérrez C, Chávez-Tapia NC, Ponciano-Rodríguez G, Uribe M, Méndez-Sánchez N.

Ann Hepatol. 2015 Nov-Dec;14(6):807-14. doi: 10.5604/16652681.1171751. Review.

PMID:
26436352
19.

Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis.

Chavez-Tapia NC, Mendiola-Pastrana I, Ornelas-Arroyo VJ, Noreña-Herrera C, Vidaña-Perez D, Delgado-Sanchez G, Uribe M, Barrientos-Gutierrez T.

Ann Hepatol. 2015 Sep-Oct;14(5):631-41. Review.

20.

The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH.

Barbero-Becerra VJ, Giraudi PJ, Chávez-Tapia NC, Uribe M, Tiribelli C, Rosso N.

Toxicol In Vitro. 2015 Oct;29(7):1753-8. doi: 10.1016/j.tiv.2015.07.010. Epub 2015 Jul 14.

PMID:
26187275

Supplemental Content

Loading ...
Support Center